Grapefruit extract shows anti-diabetes potential

By Stephen Daniells

- Last updated on GMT

Related tags: Dietary supplement, Nutrition

An antioxidant extracted from grapefruit may help the liver break down fat and improve insulin sensitivity, according to new data from the Hebrew University of Jerusalem and Massachusetts General Hospital.

Naringenin, a compound derived from the bitter flavor of grapefruits and other citrus fruits, was found to mimic the actions of the established pharmaceuticals Fenofibrate (lipid-lowering action) and Rosiglitazone (anti-diabetic action), according to findings published in the online journal PLoS ONE​.

If the results can be repeated in human studies, the dietary supplement may become a staple for people with elevated blood lipid levels (hyperlipidemia), type-2 diabetes, and perhaps metabolic syndrome.

Naringenin science

It is not the first time that naringenin has been reported to have potential for people suffering from the metabolic syndrome and related conditions. Indeed, last year scientists from the University of Western Ontario reported positive results in mice (Diabetes​, Vol. 58, pp. 2198-2210), while the cholesterol lowering potential of grapefruits has also been reported (Journal of Agricultural and Food Chemistry​, 2006, Vol. 54, pp 1887-1892).

"It is a fascinating find,"​ said Yaakov Nahmias, PhD, from the Hebrew University of Jerusalem. "We show the mechanism by which naringenin increases two important pharmaceutical targets, PPAR-alpha and PPAR-gamma, while blocking a third, LXR-alpha. The results are similar to those induced by long periods of fasting".

According to the researchers, on eating a meal the blood is flushed with sugars, which activates LXR-alpha and causes the liver to create fatty acids for long-term storage. This processed is reversed during fasting, they note, and fatty acids are released by fat cells, thereby activating PPAR-alpha in the liver, and are broken down to ketones. A similar process, involving PPAR-gamma, increases sensitivity to insulin, they said.

"Dual PPAR-alpha and PPAR-gamma agonists, like naringenin, were long sought after by the pharmaceutical industry,"​ added Nahmias, "but their development was plagued by safety concerns. Remarkably, naringenin is a dietary supplement with a clear safety record. Evidence suggests it might actually protect the liver from damage."

Study details

Nahmias and his co-workers studied the effects of naringenin in liver cells at concentrations ranging from zero to 240 micromoles. Results showed that the citrus compound activated both PPAR-alpha and PPAR-gamma, while also binding to LXR-alpha, which effectively blocked its activation.

“The potential of using a naturally occurring dietary supplement to regulate lipid metabolism is appealing as this by product of the grapefruit juice industry is non-toxic, cheap, and has demonstrated anti-inflammatory properties,” ​said the researchers.

“This is especially important in the context of the rising costs of cardiovascular care, estimated by the [American Heart Association] to rise above $500 billion this year.

“Naringenin ability to inhibit [a] target of statins, while upregulating PPAR-alpha, the target of fibrates, suggest it can naturally find its place in the routine treatment of hyperlipidemia,”​ they concluded.

Source: PLoS ONE
​Published and available online, http://dx.plos.org/10.1371/journal.pone.0012399
“Transcriptional Regulation of Human and Rat Hepatic Lipid Metabolism by the Grapefruit Flavonoid Naringenin: Role of PPARa, PPARc and LXRa”
Authors: J. Goldwasser, P.Y. Cohen, E. Yang, P. Balaguer, M.L. Yarmush, et al.

Related news

Show more

Related products

show more

Setria® is leading the way!

Setria® is leading the way!

Kyowa Hakko USA | 09-Nov-2018 | Technical / White Paper

The data is in! Setria® Glutathione is the No. 1 selling brand of glutathione in natural product supermarkets, according to SPINS, an industry source of...

K2 for Heart Health? MenaQ7 Only Proven, Patented

K2 for Heart Health? MenaQ7 Only Proven, Patented

NattoPharma USA, Inc. | 22-Oct-2018 | Research Study

Vitamin K2 has earned media and the medical community’s attention due to a strong body of evidence showing it simultaneously supports bone and cardiovascular...

Curcumin: Do all roads lead to gold?

Curcumin: Do all roads lead to gold?

Sabinsa Corporation | 01-Oct-2018 | Technical / White Paper

Scientific research and clinical studies in the modern era validate turmeric’s traditional use, particularly looking at curcuminoids produced by the rhizome...

Related suppliers

2 comments

grapefruit & diabetics

Posted by Beverly,

/since becoming a diabetic in 1997,I was told to avoid eating grapefruit because it render's the medication helpless!! So what to do????

Report abuse

Grapefruit extract and diabetes

Posted by Max Aspinall,

Hi. Always interested in Stephen Daniels articles. But so often this happen. Science has totally the wrong end of the stick. Quoting from the article. "was found to mimic the actions of the established pharmaceuticals Fenofibrate (lipid-lowering action) and Rosiglitazone (anti-diabetic action)" is completely untrue. Grapefruit have been on the planet as a food since before recorded history. Therefore the drugs are mimicing the grapefruit extract and all the science is saying is that the grapefruit is still better at doing the job. So teach the patients to eat food correctly instead of handing out drugs.

Report abuse

Follow us

Featured Events

View more

Products

View more

Webinars